ProCE Banner Activity

Patient Safety Guide for Erdafitinib and Enfortumab Vedotin: What to Look for and What to Report to Your Healthcare Team

PDF
Download this PDF patient safety guide for a quick resource on signs and symptoms of specific AEs patients should look for while they are receiving erdafitinib or enfortumab vedotin.

Released: January 06, 2021

Expiration: January 05, 2022

Share

Faculty

Susan Knight

Susan Knight, PT, PCS

Physical Therapist
Los Angeles, California

Susan Kralian

Susan Kralian, PhD

Editorial Contributor

Kinjal Patel

Kinjal Patel, PharmD, BCOP

Clinical Oncology Pharmacist
Department of Oncology
Fox Chase Cancer Center
Philadelphia, Pennsylvania

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Astellas Seattle Genetics

Janssen administered by Scientific Affairs

Faculty Disclosure

Primary Author

Susan Knight, PT, PCS

Physical Therapist
Los Angeles, California

Susan Kralian, PhD

Editorial Contributor

Kinjal Patel, PharmD, BCOP

Clinical Oncology Pharmacist
Department of Oncology
Fox Chase Cancer Center
Philadelphia, Pennsylvania